Events, News, Presentations, Press Releases
Sutro Biopharma to Participate in the Jefferies Healthcare Conference SOUTH SAN FRANCISCO, Calif., May 31, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...
Events, News, Presentations
2023 American Society of Pediatric Hematology / Oncology (ASPHO) Annual Meeting – Poster A Novel Therapy for Refractory CBFA2T3::GLIS2-associated AMKL Using STRO-002 And Plerixafor...
Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference SOUTH SAN FRANCISCO, Calif., May 8, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...
Events, News, Presentations
2023 American Association for Cancer Research Annual Meeting (AACR) – Poster Abstract #4849: The anti-ROR1 ADC STRO-003 demonstrates immune-modulating properties that may enhance checkpoint blockade Andrew McGeehan, Sihong Zhou, Dayson Moreira, Robert Yuan, Indrani...